Main > ENDOCRINOLOGY > Diabetes. Treatment > Meglitinide Class Drugs > NateGlinide. > NonGeneric Nateglinide > Patent. > Claims > Claim 1: Compn Nateglinide (0.1-35% > ); Sugar(24-46%); & > MicroCrystalline Cellulose(17-23%)



MicroCrystalline Cellulose(17-23%)'s subsections
Claim 2: Sugar: Lactose. Claim 4:

MicroCrystalline Cellulose(17-23%)'s products
This section has no products